Century Therapeutics (IPSC) News
NASDAQ: IPSCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
IPSC news summary
We found 4 recent headlines mentioning Century Therapeutics (IPSC): 0 in the past week and 3 in the past 30 days, most often from Nasdaq, GlobeNewswire. IPSC is making an outsized move today, down 11.74% at $1.17, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Century Therapeutics Reports Third Quarter 2026 Financial Results", was published by Nasdaq on Nov 12, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Century Therapeutics headlines
- Century Therapeutics Reports Third Quarter 2026 Financial ResultsCentury Therapeutics, Inc. reported its financial results for the third quarter ended September 30, 2026, and provided updates on its clinical pipeline. The company reported cash, cash equivalents,…NasdaqIPSC, HEI.A
- Century Therapeutics, Inc. Q3 Loss Declines(RTTNews) - Century Therapeutics, Inc. (IPSC) released Loss for third quarter of -$23.453 millionNasdaqIPSC, BF.A
- Century Therapeutics Reports Third Quarter 2026 Financial Results and Business UpdatesPHILADELPHIA, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies…GlobeNewswire
- Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in LondonPHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies…GlobeNewswire